125I-labeled anti-bFGF monoclonal antibody inhibits growth of hepatocellular carcinoma

doi:10.3748/wjg.v22.i21.5033

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 22, Issue 21

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7783)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series.

Item

Count

PDF

508

WORD

357

HTML

3343

Figures (1-4)

197

Sum=4405

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1031

Download

2347

Sum=3378

Jun 7, 2016 (publication date) through Jul 5, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. Jun 7, 2016; 22(21): 5033-5041
Published online Jun 7, 2016. doi: 10.3748/wjg.v22.i21.5033

Full Size Figure Download Figure

Figure 2 Radioactivity and titer of purified ¹²⁵I-bFGF mAb. A: Product peak of purified ¹²⁵I-bFGF mAb tested by gamma radiation counter GC-1200; B: Titer of purified ¹²⁵I-bFGF mAb stock solution assayed by indirect ELISA.

Citation: Hu PH, Pan LH, Wong PTY, Chen WH, Yang YQ, Wang H, Xiang JJ, Xu M. ¹²⁵I-labeled anti-bFGF monoclonal antibody inhibits growth of hepatocellular carcinoma. World J Gastroenterol 2016; 22(21): 5033-5041
URL: https://www.wjgnet.com/1007-9327/full/v22/i21/5033.htm
DOI: https://dx.doi.org/10.3748/wjg.v22.i21.5033